861 EXTENDED LOW-DOSE METRONOMIC CHEMOTHERAPY IN RATS WITH CHEMICALLY INDUCED HEPATOCELLULAR CARCINOMA

2010 ◽  
Vol 52 ◽  
pp. S335
Author(s):  
J.W. Jang ◽  
S.T. Park ◽  
G.D. Kim ◽  
J.Y. Choi ◽  
S.K. Yoon ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Low Dose ◽  
Metronomic Chemotherapy ◽  
Chemically Induced

523 ANTICANCER EFFECT OF LOW-DOSE METRONOMIC CHEMOTHERAPY IN A RAT MODEL OF HEPATOCELLULAR CARCINOMA

2009 ◽  
Vol 50 ◽  
pp. S194-S195
Author(s):  
J.W. Jang ◽  
S.T. Park ◽  
G.D. Kim ◽  
H.J. Kuh ◽  
S.H. Bae
Keyword(s):  
Hepatocellular Carcinoma ◽  
Rat Model ◽  
Low Dose ◽  
Metronomic Chemotherapy ◽  
Anticancer Effect

scholarly journals Metronomic chemotherapy for advanced diffuse hepatocellular carcinoma in a dog

2021 ◽  
Vol 14 (3) ◽  
pp. 199-205
Author(s):  
Paloma Silva ◽  
◽  
Mayara de Souza ◽  
Ellen Cavalcanti ◽  
Victoria Fonseca ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Palliative Care ◽  
Liver Tumor ◽  
Low Dose ◽  
Standard Treatment ◽  
Liver Tumors ◽  
Metronomic Chemotherapy ◽  
Presumptive Diagnosis ◽  
Primary Liver Tumors ◽  
Low Dose Naltrexone

Primary liver tumors represent 0.6% to 1.3% of neoplasms in dogs. Hepatocellular carcinoma (HCC) is the most common liver tumor. It is divided into three morphological groups: massive, nodular and diffuse. The presumptive diagnosis is made through imaging tests, such as ultrasound, although confirmation is made by histopathology. Surgery remains the treatment of choice for massive tumors, but there is no standard treatment for nodular and diffuse forms. This study aimed to report a case of prolonged survival in a dog with diffuse HCC, treated with metronomic chemotherapy and palliative care including non-steroidal anti-inflammatory and low-dose naltrexone.

Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization

ACS Nano ◽  
2021 ◽  
Vol 15 (2) ◽  
pp. 2933-2946
Author(s):  
Yuyi Qian ◽  
Qiufang Liu ◽  
Panli Li ◽  
Yaobao Han ◽  
Jianping Zhang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Low Dose ◽  
Iodine 131 ◽  
Long Acting

Low dose 1-hexylcarbamoyl-5-fluorouracil (HCFU) recommended for cirrhotic patients with hepatocellular carcinoma

1989 ◽  
Vol 25 (8) ◽  
pp. 1191-1195 ◽  
Author(s):  
Kenji Takenaka ◽  
Takashi Kanematsu ◽  
Mitsuo Shimada ◽  
Keizo Sugimachi
Keyword(s):  
Hepatocellular Carcinoma ◽  
Low Dose ◽  
Cirrhotic Patients
Sign in / Sign up

Export Citation Format

Share Document